| INTRODUCTION
Cholangiopathy in critically ill patients, so-called intensive care unit (ICU) cholangiopathy, is a recently described ischaemic-like form of cholangiopathy. The first case was reported in 2001 by Scheppach et al. 1 Reports of isolated cases or small series have mostly originated from intensive care units, in patients with polytrauma, infection, burn, major surgery or respiratory failure. [1] [2] [3] ICU cholangiopathy is characterised by the formation of biliary casts at an early stage.
Subsequent changes include the progressive destruction of intrahepatic bile ducts with multifocal strictures and dilatations. [2] [3] [4] Rapid progression to acute liver failure has been reported. 3 Average survival time, without liver transplantation, is only 13 months. [5] [6] [7] Pathogenesis has been poorly investigated. 
| PATIENTS AND METHODS
Cases were retrospectively identified through a survey conducted in MR cholangiography, (6) contrast-enhanced sequences using extracellular contrast agents. All sequences including native and 3D MIP (Maximal intensity projection) reconstructions were analysed on a workstation. For each patient, the following items were studied using a standardised scale: intrahepatic biliary duct abnormalities, main bile duct abnormalities, abnormalities of the hepatic parenchyma, parenchymal enhancement after injection, enhancement of bile duct walls, hepatic arterial abnormalities, signs of portal hypertension (splenomegaly, portosystemic collaterals) and morphological changes of the liver.
Treatment modalities during follow-up were collected including:
endoscopic treatment, ursodeoxycholic acid therapy and liver transplantation.
| Statistical analysis
All results are expressed as median and range. Categorical data are expressed as frequency and percentage.
| RESULTS
We identified 19 patients with cholangiopathy, 3 of whom were excluded from analysis because of mesenteric deinsertion in one, hepatic artery dissection and inability to review the images in the others.
Finally, 16 patients were included (11 male, 5 female). The median age at diagnosis was 52 years . Seven patients had at least one cardiovascular risk factors on admission (4 patients were current smokers, 3 had hypercholesterolemia, 1 arterial hypertension, 1 diabetes). None of the patients reported alcohol misuse. One patient had received chemotherapy for B-cell lymphoma. One patient had a documented MDR3 (ABCB4) mutation. As shown in Table 1 , extensive burns and polytrauma were the predominant rea- The median duration of ICU stay was 72 days (range: 1-172). As presented in Table 2 , the increase in serum AP levels started after a median time of 11 days, reaching a peak of 15 on average and at Three patients were lost to follow-up after a median delay of 5.3 months (4.9-30.9), leaving 13 patients for outcome analysis.
Median follow-up was 20.6 months (range: 4.7-71.8) ( Table 3 ). All The findings of our multicentre survey in liver units independently validate previously reported observations in ICU based surveys; notably a mean age of 50 years, a male predominance, and a rapid development of cholestasis after admission to ICU in patients who had no prior history of liver disease and normal liver function tests before admission. [2] [3] [4] Cholestatic liver function tests are very common in ICU, due to sepsis, whatever the origin, or due to parenteral feeding or are druginduced, however, the vast majority of such cases do not have demonstrable cholangiopathy. MRI is indicated when cholestasis persists after recovery from the ICU stay and with particularly elevated levels of alkaline phosphatase or when clinical features suggest biliary complications such as cholangitis.
A second strength of this present survey was the availability of long-term follow-up data in a specific subset of patients having survived ICU stay, a population of major interest for hepatologists. The outcome of cholangiopathy seems better than that reported in the literature, as described in Table 4 . Indeed, most published cases have been reported by intensivists, who diagnosed severe cholangiopathy, cholangitis, liver abcesses and poor outcome without transplantation during ICU stay. Kulaksiz et al in 2008 estimated a median survival time of 13 months without liver transplantation. 5 After a median follow-up of 20.6 months, 11 of our patients (68.8%) were alive without liver transplantation, including 9 with cholestasis but without jaundice. However, two patients died due to acute liver failure, pointing to an extreme variability in the expression and outcome of the disease. These two patients presented to ICU with early severe disease as described in previously reported surveys. The design of our study does not allow for the identification of prognostic factors for the severity of bile duct disease.
In our study, most patients had burns and trauma (11 cause for admission to ICU. Furthermore, severe burns require prolonged care and thus allowed for prolonged surveillance. Moreover, in ICU the death rate for patients with burns is lower than for all other pathologies (25% vs 50-70%), probably because these patients are younger, with fewer comorbidities and a different pathophysiology for critical conditions.
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The pathophysiology of ICU cholangiopathy in critically ill patients is likely complex and multifactorial, because it appears to be rare and to affect patients with diverse underlying conditions. Unlike the hepatic parenchyma, the intrahepatic biliary tree is exclusively supplied by the hepatic arterial branches, via the peribiliary vascular plexus. 13 Ischaemia due to hypovolaemia and hypoxaemia could be the first hit in cholangitis in critically ill patients, vasoconstrictive therapy might constitute an aggravating factor. 3, 14 In our cohort, MR imaging findings showed no damage of the distal common bile duct in any of our 16 patients, which confirmed the findings of Benninger et al in 5 patients using ERCP. 10 Unlike the intrahepatic biliary tree, which is exclusively supplied by the hepatic arterial branches, the common bile duct is also supplied by gastroduodenal arterial branches. 15 All these elements argue for the involvement of hepatic arterial microcirculation.
The clinical and imaging features of ICU cholangiopathy described here are very similar to those described in cases of ischaemic cholangiopathy after liver transplantation including bile cast formation or bilomas and the aspect of primary sclerosing cholangitis.
Several factors likely contribute to arterial ischaemia at liver 
